Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Trial of Endoxifen Gel Versus Placebo Gel in Women Undergoing Breast Surgery
NCT03317405Phase 1Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Oct 2018
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial in breast cancer comparing Cohort I (endoxifen hydrochloride) with Cohort II (placebo) (2 cohorts). Primary endpoint: Number of Participants With Dermal Toxicity on Breast Skin at the Application Site up to 60 days. Started Oct 2018; status: active, not recruiting.
02
Drugs
z-endoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03317405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317405.